76
Views
2
CrossRef citations to date
0
Altmetric
SHORT COMMUNICATIONS

Movement Disorders and MDMA Abuse

&
Pages 203-204 | Published online: 09 Sep 2011

REFERENCES

  • Baggot , M. , Mendelson , J. and Jones , R. 1999 . More about Parkinsonism after taking ecstasy [correspondence] . New England Journal of Medicine , 341 : 1400 – 1 .
  • Borg , G. 1999 . More about Parkinsonism after taking ecstasy [correspondence] . New England Journal of Medicine , 341 : 1400
  • Colado , M. , O'Shea , E. and Green , A. 2003 . Acute and long term effects of MDMA on cerebral dopamine biochemistry and function . Psychopharmacology , 173 : 249 – 63 .
  • McKenna , D. and Peroutka , S. 1990 . Neurochemistry and neurotoxicity of 3,4 – methylenedioxymethamphetamine . Journal of Neurochemistry , 54 ( 1 ) : 14 – 22 .
  • Mintzer , S. , Hickenbottom , S. and Gilman , S. 1999 . Parkinsonism after taking ecstasy . New England Journal of Medicine , 340 : 1443
  • Munetz , M. and Benjamin , S. 1988 . How to examine patients using the Abnormal Involuntary Movement Scale . Hospital and Community Psychiatry , 39 ( 11 ) : 1172 – 77 .
  • Ricaurte , G. , Yuan , J. and McCann , U. 2000 . 3–4-Methy lenedioxymethamphetamine (Ecstasy)-induced serotonin neurotoxicity: Studies in animals . Neuropsychobiology , 42 ( 1 ) : 5 – 10 .
  • Semple , D. , Ebmeir , K. , Glabus , M. , O'Carroll , R. and Johnstone , E. 1999 . Symptoms of MDMA abuse . British Journal of Psychiatry , 175 : 63 – 9 .
  • Sewell , R. and Cozzi , N. 1999 . More about Parkinsonism after taking ecstasy [correspondence] . New England Journal of Medicine , 341 : 1400
  • Spruit , I. 2001 . Monitoring synthetic drug markets, trends and public health . Substance Use and Abuse , 36 ( 1–2 ) : 23 – 47 .
  • Strote , J. , Lee , J. and Wechsler , H. 2002 . Increasing MDMA use among college students: results of a national survey . Journal of Adolescent Health , 30 ( 1 ) : 64 – 72 .
  • Suilleabhain , P. and Giller , C. 2003 . Rapidly progressive Parkinsonism in a self-reported user of ecstasy and other drugs . Movement Disorders , 18 ( 11 ) : 1378 – 1400 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.